Docetaxel Induced Toxic Erythema of Chemotherapy: A Case Report


  • Nouf M. Bajawi Department of Dermatology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
  • Tara Z. Al-Faddagh Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
  • Sultan M. Bajawi Jazan Health affairs, Ministry of Health, Jazan, Saudi Arabia
  • Sahar H. Al-Natour Department of Dermatology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia


Toxic Erythema, Chemotherapy, erythrodysesthesia, hand-foot syndrome


Toxic erythema of chemotherapy (TEC) refers to a group of chemotherapy-induced cutaneous toxicities. It is important to raise awareness of TEC clinical presentation to prevent misdiagnosis and treat them promptly. We present a patient diagnosed with invasive ductal carcinoma of the left breast who had undergone mastectomy with axillary dissection who developed TEC after docetaxel chemotherapy infusion.


Nikolaou V, Syrigos K, Saif MW. Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf. 2016 Dec;15(12):1625-1633. doi: 10.1080/14740338.2016.1238067. Epub 2016 Oct 8. PMID: 27718746.

Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol 2008; 59:524–9.

Miller KK, Gorcey L, McLellan BN. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol. 2014 Oct;71(4):787-94. doi: 10.1016/j.jaad.2014.03.019. Epub 2014 May 1. PMID: 24795111.

Susser W.S., Whitaker-Worth D.L. Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol. 1999;40(3):367– 398. quiz 399-400.

Parker T, Coopoer DL, Seropian SE, Bolognia JL. Toxic erythema of chemotherapy following iv BU plus fludarabine for allogeneic PBSC transplant. Bone Marrow Transplant 2013; 48:646.

Sibaud V., Dalenc F., Chevreau C., Roché H., Delord J.P., Mourey L. HFS- 14, a specific quality of life scale developed for patients suffering from hand-foot Syndrome. Oncologist. 2011;16(10):1469–1478.

Gressett S.M., Stanford B.L., Hardwicke F. Management of hand-foot syndrome induced by capecitabine. J Oncol PharmPract. 2006;12(3):131–141.

Degen A., Alter M., Schenck F., Satzger I., Völker B., Kapp A. The hand- foot-syndrome associated with medical tumor therapy-classification and management. J Dtsch Dermatol Ges. 2010;9(8):652–661.

Zimmerman GC, Keeling JH, Lowry M, Medina J, Von Hoff DD, Burris HA: Prevention of docetaxel-induced erythrodysesthesia with local hypothermia. J Natl Cancer Inst 1994, 86(7):557-558.

Dow E.N., Piccolo J., Segal E.M., Charlson J.A. Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy. Cancer Treat Commun. 2015; 4:161–164.

Qiao J., Fang H. Hand-foot syndrome related to chemotherapy. Can Med Assoc J. 2012;184(15):E818.

Von Moos R., Thuerlimann B.J.K., Aapro M., Rayson D., Harrold K., Sehouli J. Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of experts. Eur J Cancer. 2008;44(6):781–790.

Coleman R.E., Biganzoli L., Canney P., Dirix L., Mauriac L., Chollet P. A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993) Eur J Cancer. 2006;42(7):882–887.

Lyass O., Uziely B., Ben-Yosef R., Tzemach D., Heshing N.I., Lotem M. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer. 2000;89(5):1037–1047.

Bun S., Yunokawa M., Tamaki Y., Shimomura A., Shimoi T., Kodaira M. Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer. Support Care Cancer. 2018;26(7):2161–2.




How to Cite

Nouf M. Bajawi, Tara Z. Al-Faddagh, Sultan M. Bajawi, & Sahar H. Al-Natour. (2023). Docetaxel Induced Toxic Erythema of Chemotherapy: A Case Report. International Journal of Sciences: Basic and Applied Research (IJSBAR), 67(1), 69–75. Retrieved from